Karla V Ballman

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Faster cyclic loess: normalizing RNA arrays via linear models
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Bioinformatics 20:2778-86. 2004
  2. ncbi Genetics and genomics: gene expression microarrays
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 118:1593-7. 2008
  3. ncbi The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Neuro Oncol 9:29-38. 2007
  4. ncbi Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
    Gaspar J Kitange
    Department of Radiation Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Neurooncol 92:23-31. 2009
  5. ncbi CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma
    Nadia N Laack
    Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Int J Radiat Oncol Biol Phys 81:476-82. 2011
  6. ncbi Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
    Gaspar J Kitange
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Neurooncol 100:177-86. 2010
  7. ncbi Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group
    Jan C Buckner
    Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    J Clin Oncol 24:3871-9. 2006
  8. ncbi Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts
    Lucy J Schmidt
    Department of Urology Research, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Prostate 69:1730-43. 2009
  9. ncbi A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy
    Tohru Nakagawa
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
    PLoS ONE 3:e2318. 2008
  10. ncbi How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:3039-44. 2005

Detail Information

Publications73

  1. ncbi Faster cyclic loess: normalizing RNA arrays via linear models
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Bioinformatics 20:2778-86. 2004
    ..Our goal was to develop a normalization technique that yields results similar to cyclic loess normalization and with speed comparable to quantile normalization...
  2. ncbi Genetics and genomics: gene expression microarrays
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 118:1593-7. 2008
  3. ncbi The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
    Karla V Ballman
    Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Neuro Oncol 9:29-38. 2007
    ..Finally, there was a strong association between progression-free survival status and overall survival. PFS6 seems to be a reasonable end point for phase II trials in patients with recurrent glioblastoma...
  4. ncbi Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
    Gaspar J Kitange
    Department of Radiation Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Neurooncol 92:23-31. 2009
    ..These data highlight one potential limitation of the evaluation of MGMT methylation by MS-PCR assay and suggest that more detailed evaluation of methylation at individual CpG sites relative to TMZ response may be worth pursuing...
  5. ncbi CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma
    Nadia N Laack
    Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Int J Radiat Oncol Biol Phys 81:476-82. 2011
    ....
  6. ncbi Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
    Gaspar J Kitange
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Neurooncol 100:177-86. 2010
    ..Collectively, these findings suggest that CD74 is expressed in a subset of high grade gliomas and may contribute to TMZ resistance...
  7. ncbi Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group
    Jan C Buckner
    Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    J Clin Oncol 24:3871-9. 2006
    ....
  8. ncbi Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts
    Lucy J Schmidt
    Department of Urology Research, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Prostate 69:1730-43. 2009
    ..In this study, we sought to determine how dutasteride is functioning at the molecular level, using a prostate cancer xenograft model...
  9. ncbi A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy
    Tohru Nakagawa
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
    PLoS ONE 3:e2318. 2008
    ..We hypothesized that an expression biomarker panel can predict which men with a rising PSA would benefit from further therapy...
  10. ncbi How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    Cynthia S Crowson
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:3039-44. 2005
    ....
  11. ncbi Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis
    Paulo J Nicola
    Dept. of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Rheum 54:60-7. 2006
    ..Eliminating the excess risk of CHF in patients with RA could significantly improve their survival...
  12. ncbi Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19
    Kristen L Drucker
    Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Genes Chromosomes Cancer 48:854-64. 2009
    ..This suggests that one or more of these candidates may play a role in glioma formation or progression...
  13. ncbi Ischemic stroke after heart failure: a community-based study
    Brandi J Witt
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA
    Am Heart J 152:102-9. 2006
    ..Stroke results in a >2-fold increase in mortality. Thus, prevention of stroke has the potential to improve survival among patients with HF, particularly among the elderly and those with diabetes or prior stroke...
  14. ncbi Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
    Joon H Uhm
    Division of Neuro Oncology, Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 80:347-53. 2011
    ..In the current study, we evaluated gefitinib, a potent EGFR inhibitor, in the treatment of adults with newly diagnosed GBM...
  15. ncbi Prospective study of quality of life in adults with newly diagnosed high-grade gliomas
    Paul D Brown
    Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Neurooncol 76:283-91. 2006
    ..To assess baseline quality of life (QOL) and its prognostic importance for adults with newly diagnosed high-grade gliomas, we analyzed QOL and outcome data prospectively collected in three phase II high-grade glioma protocols...
  16. ncbi Cardiovascular death in rheumatoid arthritis: a population-based study
    Hilal Maradit-Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:722-32. 2005
    ....
  17. ncbi A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
    Robert B Jenkins
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Cancer Res 66:9852-61. 2006
    ..Like combined 1p/19q deletion, the 1;19 translocation is associated with superior OS and progression-free survival in low-grade glioma patients...
  18. ncbi Androgen modulation of coregulator expression in prostate cancer cells
    Hannelore V Heemers
    Departments of Urology Research Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905
    Mol Endocrinol 23:572-83. 2009
    ....
  19. ncbi Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177
    Sunil Krishnan
    Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Int J Radiat Oncol Biol Phys 65:1192-9. 2006
    ..To evaluate the toxicity and maximum tolerated dose (MTD) of erlotinib plus radiation therapy (RT) in patients with glioblastoma multiforme (GBM) in a multicenter phase I trial...
  20. ncbi Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 56:820-30. 2007
    ..To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA)...
  21. ncbi A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival
    Paul D Brown
    Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Neurosurgery 57:495-504; discussion 495-504. 2005
    ..001), and greater extent of resection (P < 0.001). CONCLUSION: Baseline QOL was predictive of QOL over time. Gross total resection was associated with longer survival and improved QOL over time for patients with high-grade gliomas...
  22. ncbi Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients
    Dona E C Locke
    Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, Arizona 85259, USA
    J Pain Symptom Manage 34:628-38. 2007
    ..The data suggest that the single-item LASA scales are valid for assessing QOL of cancer patients and are an appropriate alternative when a shorter instrument is warranted...
  23. ncbi A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life
    Paul D Brown
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Clin Oncol 31:163-8. 2008
    ..To examine whether a caregiver can provide reliable proxy quality of life (QOL) ratings of their adult significant other with a newly diagnosed high-grade glioma...
  24. ncbi Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study
    Hilal Maradit-Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:402-11. 2005
    ..The risk of CHD in RA patients precedes the ACR criteria-based diagnosis of RA, and the risk cannot be explained by an increased incidence of traditional CHD risk factors in RA patients...
  25. ncbi Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
    Nicole E Marshall
    Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    J Neurooncol 77:315-20. 2006
    ..Older patients are more susceptible to hearing loss with CDDP. The low proportion of patients with clinically significant ototoxicity suggests that baseline screening is unnecessary in GBM patients...
  26. ncbi Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma
    Paul D Brown
    Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 24:5427-33. 2006
    ..To assess the cognitive performance of high-grade glioma patients, prospectively collected cognitive performance data were analyzed...
  27. ncbi Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter
    Osnat T Gurevitz
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 149:316-21. 2005
    ..CONCLUSION: When used to cardiovert atrial arrhythmias, the rectilinear biphasic waveform was associated with higher success rates and lower cumulative energies than the monophasic damped sine waveform...
  28. ncbi The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years
    Paulo J Nicola
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 52:412-20. 2005
    ..28, 95% CI 0.93-1.78). CONCLUSION: Compared with persons without RA, patients with RA have twice the risk of developing CHF. This excess risk is not explained by traditional CV risk factors and/or clinical ischemic heart disease...
  29. ncbi The incidence of stroke after myocardial infarction: a meta-analysis
    Brandi J Witt
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
    Am J Med 119:354.e1-9. 2006
    ..Further research is needed to determine the optimal stroke prevention strategies for MI survivors...
  30. ncbi Joint estimation of calibration and expression for high-density oligonucleotide arrays
    Ann L Oberg
    Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine 200 First Street SW, Rochester, MN 55905, USA
    Bioinformatics 22:2381-7. 2006
    ..The need for normalization in microarray experiments has been well documented in the literature. Currently, many analysis methods treat normalization and analysis as a series of steps, with summarized data carried forward to the next step...
  31. ncbi Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade
    Jan C Buckner
    Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Neurooncol 84:279-86. 2007
    ..Anaplastic oligoastrocytomas (AOA) are relatively uncommon high-grade gliomas. While oligodendroglial elements are thought to be associated with better outcomes, the magnitude of the difference is not clear...
  32. ncbi Long-term prognosis of inducible ventricular flutter: not an innocent finding
    Osnat Gurevitz
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 147:649-54. 2004
    ..CONCLUSION: The long-term prognosis of patients with inducible VFL is similar to that of patients with inducible SMVT, even when VFL is induced with a relatively aggressive protocol...
  33. ncbi Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence
    Horacio Murillo
    Urology Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Genes Chromosomes Cancer 45:702-16. 2006
    ..This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat...
  34. ncbi The incidence of ischemic stroke in chronic heart failure: a meta-analysis
    Brandi J Witt
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Card Fail 13:489-96. 2007
    ..We will summarize the ischemic stroke rate at various time points during follow-up among adults with chronic heart failure...
  35. ncbi Risk factor implications of incidentally discovered uncomplicated bundle branch block
    Wayne L Miller
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 80:1585-90. 2005
    ..To evaluate the long-term outcome of a community-based patient population with incidentally discovered asymptomatic and uncomplicated bundle branch block (BBB)...
  36. ncbi Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride
    Lucy J Schmidt
    Department of Urology Research, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Prostate 67:1111-20. 2007
    ....
  37. ncbi Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods
    Evanthia Galanis
    Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Neuro Oncol 8:156-65. 2006
    ....
  38. ncbi Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
    Jann N Sarkaria
    Department of Radiation Oncology, Laboratory Medicine and Pathology, and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
    Clin Cancer Res 12:2264-71. 2006
    ..The intent of the current study was to address this relationship using several EGFR-amplified glioblastoma xenografts in an orthotopic athymic mouse model...
  39. ncbi Clinical predictors of exercise capacity 1 year after cardiac transplantation
    Tat-Chi Leung
    Division of Cardiovascular Disease, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    J Heart Lung Transplant 22:16-27. 2003
    ..In estimating the impact of cardiac transplantation on exercise capacity the most important pre-transplant factors to consider are age, gender and height and weight (or, alternatively, body mass index)...
  40. ncbi Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas
    Ping Yang
    Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Cancer 103:2363-72. 2005
    ..The authors have previously described a 150-kilobase minimal deletion region in gliomas that maps to 19q13.33 and contains 3 novel candidate genes (GLTSCR1, EHD2, and GLTSCR2)...
  41. ncbi A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies
    Paul D Brown
    Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 63:1361-7. 2005
    ..CONCLUSIONS: For long-term survivors after neck dissection and irradiation, especially those who are symptomatic, ultrasonographic carotid artery screening should be considered...
  42. ncbi Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm: incidence, outcome, and determinants
    Steven J Kernis
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 110:2320-5. 2004
    ..LA enlargement is independently predictive of postoperative AF and as such, should be integrated into the clinical decision-making process in patients with MR...
  43. ncbi Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51
    Nadia N Laack
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 65:1429-39. 2006
    ..Although the numbers of patients are too small for statistical conclusions, the HDMP regimen deserves further study...
  44. ncbi Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response
    Kurt A Jaeckle
    Mayo Clinic, Rochester, NY, USA
    J Clin Oncol 24:1246-52. 2006
    ....
  45. ncbi Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors
    Osnat T Gurevitz
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Cardiovasc Electrophysiol 14:728-32. 2003
    ..At ICD implant, DFT testing is recommended in these patients and in patients with a high (>20 J) ULV before first-shock energy and the need for lead repositioning are determined...
  46. ncbi Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
    Kurt A Jaeckle
    Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    J Neurooncol 99:73-80. 2010
    ..This regimen was not significantly active and radiosensitization was not observed. Non-EIAC patients with UGT1A1*28 variant alleles appear particularly sensitive to toxicity from irinotecan...
  47. ncbi Usefulness of immunosuppression for giant cell myocarditis
    Leslie T Cooper
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
    Am J Cardiol 102:1535-9. 2008
    ..Additionally, withdrawal of immunosuppression can be associated with fatal GCM recurrence...
  48. ncbi Gender differences in C-reactive protein concentrations-confirmation with two sensitive methods
    Joseph P McConnell
    Department of Laboratory, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Clin Chem Lab Med 40:56-9. 2002
    ..0001), was independent of age differences as assessed by multiple regression analysis. The observed gender differences have important implications for the establishment of cut-off points for cardiovascular risk stratification...
  49. ncbi Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity
    Ray W Squires
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:1295-300. 2002
    ..To determine the frequency of partial normalization of the heart rate response to graded exercise and its relationship to exercise capacity in cardiac transplant recipients...
  50. ncbi B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma
    Scott E Strome
    Department of Otolaryngology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Res 63:6501-5. 2003
    ..These data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy...
  51. ncbi Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study
    Qian Shi
    Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
    Clin Trials 7:686-95. 2010
    ..Data collection and review were identified as major contributors to the cost of randomized clinical trials (RCTs)...
  52. ncbi Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation
    Shauna L Hillman
    Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 28:3002-7. 2010
    ..In March 1998, Common Toxicity Criteria (CTC) version 2.0 introduced the collection of attribution of adverse events (AEs) to study drug. We investigate whether attribution adds value to the interpretation of AE data...
  53. ncbi Elevated expressions of osteopontin and tenascin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves
    Ramanath Majumdar
    Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Cardiovasc Pathol 16:144-50. 2007
    ..The objective of this investigation was to compare the patterns of gene expression in aortas between TAV and BAV patients with the aim of identifying markers for AscAAs...
  54. ncbi P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response
    Andrea K McCollum
    Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Cancer Res 68:7419-27. 2008
    ..Taken together, our results indicate that targeting of Hsp27 and Hsp70 should be exploited to increase the clinical efficacy of Hsp90-directed therapy...
  55. ncbi Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis
    Hilal Maradit Kremers
    Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Rheum 50:3450-7. 2004
    ..09, 95% CI 1.50-2.92) when compared with non-RA subjects who maintained normal BMI throughout followup. CONCLUSION: Among patients with RA, low BMI is associated with a significantly increased risk of cardiovascular death...
  56. ncbi A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease)
    Leslie T Cooper
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Angiology 57:73-8. 2006
    ..03). In contrast to case reports of extreme tobacco dependence in the TAO population, the degree of tobacco dependence in subjects with TAO is similar to that in subjects with CAD...
  57. ncbi A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases
    BRIAN PATRICK O'NEILL
    Department of Neurology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 55:1169-76. 2003
    ..To determine whether neurosurgery (NS) or stereotactic radiosurgery (RS) provided better local tumor control and enhanced patient survival...
  58. ncbi Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis
    Roshini S Abraham
    Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Blood 105:794-803. 2005
    ..This study provides new insight into the molecular profile of clonal plasma cells and its functional relevance in the pathogenesis of light chain amyloidosis...
  59. ncbi PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer
    Donkena Krishna Vanaja
    Department of Urology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Clin Cancer Res 12:1128-36. 2006
    ..We analyzed the expression of genes to identify reliable molecular markers in the diagnosis and progression of prostate cancer...
  60. ncbi Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study
    Nadia N Laack
    Division of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Int J Radiat Oncol Biol Phys 63:1175-83. 2005
    ..Slight improvements in some cognitive areas are consistent with practice effects attributable to increased familiarity with test procedures and content...
  61. ncbi Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus
    Apoor S Gami
    Department of Internal Medicine, The Mayo Alliance for Clinical Trials, Rochester, Minnesota 55905, USA
    Am J Cardiol 91:1275-7. 2003
  62. ncbi Early effects of pharmacological androgen deprivation in human prostate cancer
    Maria Mercader
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 99:60-7. 2007
    ....
  63. ncbi Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation
    T Jared Bunch
    Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    N Engl J Med 348:2626-33. 2003
    ..The quality of life among the majority of survivors is similar to that of the general population...
  64. ncbi Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy
    Virginia V Michels
    Department of Medical Genetics, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Am J Cardiol 91:1389-92. 2003
  65. ncbi Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location
    Simone Barretto
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Vasc Med 8:95-100. 2003
    ..Low HDL-cholesterol and female sex were associated with disease severity. An aggressive approach to diagnosis and treatment may be warranted as atherosclerosis in other arterial beds was prevalent in half of the patients...
  66. ncbi Obstructive sleep apnea and the recurrence of atrial fibrillation
    Ravi Kanagala
    Mayo Clinic, 200 First St SW, Rochester, Minn 55905, USA
    Circulation 107:2589-94. 2003
    ..Appropriate treatment with CPAP in OSA patients is associated with lower recurrence of AF...
  67. ncbi Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases, Department of Internal Medicine, W16 Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Atherosclerosis 168:315-22. 2003
    ..On multivariate analysis, the MTRR genotypes were not associated with serum homocysteine or with significant CAD...
  68. ncbi Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
    Christopher E Pelloski
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:2288-94. 2007
    ..We sought to evaluate the clinical significance of GBM subtypes as defined by EGFRvIII status...
  69. ncbi Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease
    Ilan S Weisberg
    Department of Human Genetics, McGill University Health Center Montreal Children s Hospital, 4060 Ste Catherine West, Room 200, Montreal, Canada H3Z 2Z3
    Atherosclerosis 167:205-14. 2003
    ....
  70. ncbi The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial
    Bryan F Meyers
    Department of Surgery, Washington University School of Medicine, St Louis, MO
    J Thorac Cardiovasc Surg 133:738-45. 2007
    ....
  71. ncbi Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)
    Leslie T Cooper
    J Am Coll Cardiol 44:2410-1. 2004
  72. ncbi Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia
    Michael Glikson
    Sheba Medical Center, Tel Hashomer, Israel
    J Cardiovasc Electrophysiol 15:658-64. 2004
    ..No predictors could be found for high and low risk for unstable arrhythmias. These findings support ICD treatment for stable VT survivors...
  73. ncbi Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level
    Loretta D Spotila
    Department of Bioscience and Biotechnology, College of Arts and Sciences, Drexel University, Philadelphia, PA, USA
    Am J Epidemiol 158:871-7. 2003
    ..Failure to examine younger patients separately may explain why some studies have found no association between the genotype and cardiovascular disease...